Semaglutide and GLP-1 Therapy in Ontario: A Physician's Framework
When GLP-1 therapy is appropriate, what monitoring matters, brand vs. compounded preparations, and how semaglutide fits into a longevity-oriented practice.
Read moreWhen GLP-1 therapy is appropriate, what monitoring matters, brand vs. compounded preparations, and how semaglutide fits into a longevity-oriented practice.
Read moreWhy weight loss plateaus are metabolic and hormonal, and how integrating pharmacotherapy into a foundation of training, nutrition, sleep, and hormone balance produces durable results.
Read moreED is one of the earliest warning signs of cardiovascular and metabolic disease, often arriving three to five years before a heart attack. Why a thorough workup matters.
Read moreHow blood sugar dysregulation disrupts testosterone, estrogen, thyroid, and cortisol, and why glucose and insulin are central to hormonal health.
Read moreWhy caloric restriction stops working in your 40s, how hormonal and metabolic changes drive weight loss resistance, and what a physician-led approach looks like.
Read moreThe bidirectional relationship between insulin resistance and low testosterone. How metabolic dysfunction drives hormonal decline and how to break the cycle.
Read moreWhy fasting insulin is the earliest and most sensitive marker for metabolic dysfunction, how it connects to hormonal health, and why your doctor probably isn't ordering it.
Read more